Expanding in Africa since 1990, Quintiles provides fully integrated services for Phase II-IV clinical studies and commercialization to the pharmaceutical industry. These locations are part of our infrastructure that enables the transfer of best practices around the globe.
Read more about:
Sub-Saharan Africa fact sheet about Phase II/III trials. The gateway to Africa: Access to expanded clinical resources and patient populations in South Africa and beyond.
October 19, 2011 – The acquisition of VCG & Associates and VCG BIO strengthens Quintiles’ comprehensive commercial services in sales and brand solutions, product solutions, product distribution and market access.
